Locations:
Search IconSearch
April 10, 2018/Neurosciences

PACNS or RCVS? Differences in Imaging and Test Results

Why precise diagnosis matters

By Rula Hajj-Ali, MD, and Leonard Calabrese, DO

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

An extensive workup is required to rule out primary angiitis of the central nervous system (PACNS), a devastating disease in which exclusive inflammation and destruction of vessels in the CNS cause progressive, debilitating neurological deficits. Prognosis improves greatly with proper treatment, but with nonspecific tests and many confounding mimics, diagnosis can be tricky.

One of PACNS’s closest mimics is reversible cerebral vasoconstriction syndrome (RCVS). Distinguishing between RCVS and PACNS is critical because the treatment protocol is so vastly different. Misdiagnosing PACNS as RCVS can deprive a patient of medications that prolong survival and improve outcomes. We offer a brief overview of differences in the results of diagnostic tests below. See this post for differences in clinical presentation. A future post will focus on management.

Diagnostic test results

Cerebrospinal fluid (CSF) analysis is essential in the differentiation between PACNS and RCVS and in excluding infections and malignancies. PACNS cases will show lymphocyte-predominant pleocytosis, elevated protein levels and normal glucose levels. In RCVS, normal CSF is the rule, unless the CSF is contaminated by subarachnoid or parenchymal hemorrhages.

Neuroimaging in PACNS cases is always abnormal. Ischemic infarctions are the most common lesions and are often multiple and bilateral. Nonspecific high-intensity lesions are also common in PACNS as visualized on T2-weighted magnetic resonance imaging (MRI) with a fluid-attenuated recovery sequence. RCVS is usually but not always abnormal on neuroimaging. Upon initial presentation, 20 percent of patients may have normal neuroimaging. Edema is a common finding, and computed tomography can show convexity subarachnoid hemorrhage or intracranial hemorrhage, both more common in RCVS.

Advertisement

Cerebrovascular imaging is always abnormal in RCVS and usually abnormal in PACNS. Stenosis and dilation visualized by direct or indirect angiography are not specific to either condition. Involvement of vascular beds in RCVS is usually bilateral and affecting multiple territories which may not be true in PACNS. Further, the cerebrovascular abnormalities in RCVS are dynamic and improve over time.

In the lab, both PACNS and RCVS will test normal for C-reactive protein, erythrocyte sedimentation rate, complete blood count and complete metabolic profile. Serologic tests for rheumatologic, autoinflammatory, autoimmune, malignant and infectious diseases are negative in PACNS and RCVS.

Advances in neuroimaging such as the use of 3-Tesla high resolution MRI specifically to assess the vessel wall hold promise in differentiating between both entities. The vessel walls in RCVS do not show enhancement while in PACNS enhancement occurs.

A note on the gold standard

Brain biopsy is the often-feared, underutilized gold standard in the diagnosis of PACNS. An open-wedge procedure is considered low risk, and an experienced neurosurgeon working as part of a multidisciplinary team can perform a biopsy with greater than 80 percent sensitivity and 90-100 percent specificity. Finding inflammation in the vessel wall is characteristic of PACNS, while brain biopsies are normal in RCVS.

Dr. Hajj-Ali is Associate Director of the Center for Vasculitis Care and Research in the Department of Rheumatic and Immunologic Diseases. Dr. Calabrese is Director of the R.J. Fasenmyer Center for Clinical Immunology.

Advertisement

Advertisement

Related Articles

teenage girl in a wooded outdoor setting
Accelerated Aging May Be Present in the Youngest Patients With Multiple Sclerosis

Case-control study yields evidence of epigenetic aging in pediatric-onset MS

people in the spacious lobby of a medical building
How Patients and Caregivers Are Shaping Our New Neurological Building

Input from these central stakeholders is leading us to design for healing and hope

excerpt of a multicolored heatmap
Rapidly Progressive Alzheimer’s Disease Has Distinct CSF Protein Signatures

Proteins related to altered immune response are potential biomarkers of the rare AD variant

two doctors against a decorative background with podcast overlay in the middle
June 16, 2025/Neurosciences/Podcast
Brachial Plexus Injuries: When, How and Why to Intervene (Podcast)

Multidisciplinary perspectives on the importance of early referral and more

woman in bed looking at her phone and smiling
App Helps Patients Answer ‘How Are You Sleeping?’

Screening tool helps flag conditions that warrant further attention

Dr. Alexandra Bonner against a decorative background with podcast overlay
June 2, 2025/Neurosciences/Podcast
Spinal Muscular Atrophy: Progress Continues Against a Grave Neuromuscular Disorder (Podcast)

As genetic insights refine diagnosis, research abounds on current and emerging therapies

four colored brain scans against black background
May 28, 2025/Neurosciences/Epilepsy
Clinical Application of MR Fingerprinting in Epilepsy Advances With NIH Grant Renewal

Researchers pair quantitative imaging with AI to improve surgical outcomes in nonlesional epilepsy

person walking with a stick-figure overlay on his body
A Peek Inside a Transformative Care Space in Our New Neurological Building

Novel ‘assessment center’ will be a partner in care by serving as an engine of structured data collection

Ad